256 related articles for article (PubMed ID: 30440154)
1. [Effect of 2% ganciclovir eye drops on cytomegalovirus positive Posner-Schlossman syndrome].
Zhai RY; Xu H; Kong XM; Wang ZJ
Zhonghua Yan Ke Za Zhi; 2018 Nov; 54(11):833-838. PubMed ID: 30440154
[No Abstract] [Full Text] [Related]
2. Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy.
Su CC; Hu FR; Wang TH; Huang JY; Yeh PT; Lin CP; Wang IJ
Am J Ophthalmol; 2014 Nov; 158(5):1024-1031.e2. PubMed ID: 25124264
[TBL] [Abstract][Full Text] [Related]
3. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis.
Koizumi N; Miyazaki D; Inoue T; Ohtani F; Kandori-Inoue M; Inatomi T; Sotozono C; Nakagawa H; Horikiri T; Ueta M; Nakamura T; Inoue Y; Ohashi Y; Kinoshita S
Br J Ophthalmol; 2017 Feb; 101(2):114-119. PubMed ID: 27142389
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Topical Ganciclovir and Corticosteroids Preserve Corneal Endothelial Function in Cytomegalovirus Corneal Endotheliitis.
Fan NW; Chung YC; Liu YC; Liu CJ; Kuo YS; Lin PY
Cornea; 2016 May; 35(5):596-601. PubMed ID: 26967107
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of virus-related uveitic secondary glaucoma: focus on cytomegalovirus and varicella zoster virus.
Fan X; Li Z; Zhai R; Sheng Q; Kong X
BMC Ophthalmol; 2022 Mar; 22(1):130. PubMed ID: 35317777
[TBL] [Abstract][Full Text] [Related]
6. [Determination of cytomegalovirus IgG synthesis by the albumin correction in the aqueous humor of posner-schlossmann syndrome].
Wang XL; Wang ZJ; Tang L; Cao WW; Sun XH
Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):104-108. PubMed ID: 28260360
[No Abstract] [Full Text] [Related]
7. The Effect of Topical Ganciclovir and Corticosteroid on Cytomegalovirus Corneal Endotheliitis in Korean Patients.
Hwang JH; Ha M; Park Y; Chung SH
Ocul Immunol Inflamm; 2019; 27(2):338-344. PubMed ID: 29953306
[TBL] [Abstract][Full Text] [Related]
8. Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome.
Sobolewska B; Deuter C; Doycheva D; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):117-24. PubMed ID: 24287937
[TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis of Recurrent Cytomegalovirus Uveitis with Topical Ganciclovir].
Hänsli C; Meier F; Barthelmes D; Böni C
Klin Monbl Augenheilkd; 2019 Apr; 236(4):511-515. PubMed ID: 30763957
[TBL] [Abstract][Full Text] [Related]
10. The Analysis of Dynamic Changes and Prognosis of Posner-Schlossman Syndrome with Cytomegalovirus Infection and Antiviral Therapy.
Sheng Q; Zhai R; Fan X; Kong X
J Ophthalmol; 2021; 2021():6687929. PubMed ID: 34123414
[TBL] [Abstract][Full Text] [Related]
11. 2% Ganciclovir Eye Drops Control Posner-Schlossman Syndrome Relapses With/Without Cytomegalovirus Intraocular Reactivation.
Sheng Q; Zhai R; Fan X; Kong X
Front Med (Lausanne); 2022; 9():848820. PubMed ID: 35355609
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus Anterior Uveitis: Clinical Characteristics and Long-term Outcomes in a French Series.
Touhami S; Qu L; Angi M; Bojanova M; Touitou V; Lehoang P; Rozenberg F; Bodaghi B
Am J Ophthalmol; 2018 Oct; 194():134-142. PubMed ID: 30055154
[TBL] [Abstract][Full Text] [Related]
13. Relationships between the clinical characteristics and copy numbers of DNA of cytomegalovirus determined by real-time PCR.
Yoshimura A; Araki-Sasaki K; Toyokawa N; Fujiwara R; Jho N; Gomi F
Int Ophthalmol; 2020 Sep; 40(9):2297-2305. PubMed ID: 32418075
[TBL] [Abstract][Full Text] [Related]
14. Topical Ganciclovir for Prophylaxis of Cytomegalovirus Endotheliitis in Endothelial Keratoplasty.
Basilious A; Chew HF
Cornea; 2019 Jan; 38(1):120-122. PubMed ID: 30379718
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients.
Chee SP; Bacsal K; Jap A; Se-Thoe SY; Cheng CL; Tan BH
Am J Ophthalmol; 2008 May; 145(5):834-40. PubMed ID: 18255045
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and features of keratitis with quantitative polymerase chain reaction positive for cytomegalovirus.
Kandori M; Inoue T; Takamatsu F; Kojima Y; Hori Y; Maeda N; Tano Y
Ophthalmology; 2010 Feb; 117(2):216-22. PubMed ID: 19969369
[TBL] [Abstract][Full Text] [Related]
17. Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study.
Waduthantri S; Zhou L; Chee SP
PLoS One; 2018; 13(1):e0191850. PubMed ID: 29377953
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus-positive corneal stromal edema with keratic precipitates after penetrating keratoplasty: a case-control study.
Chee SP; Jap A; Ling EC; Ti SE
Cornea; 2013 Aug; 32(8):1094-8. PubMed ID: 23538617
[TBL] [Abstract][Full Text] [Related]
19. The characteristics of Posner-Schlossman syndrome: A comparison in the surgical outcome between cytomegalovirus-positive and cytomegalovirus-negative patients.
Murata K; Ishida K; Ozawa K; Sawada A; Mochizuki K; Yamamoto T
Medicine (Baltimore); 2019 Nov; 98(48):e18123. PubMed ID: 31770242
[TBL] [Abstract][Full Text] [Related]
20. Ganciclovir for the treatment of anterior uveitis.
Mietz H; Aisenbrey S; Ulrich Bartz-Schmidt K; Bamborschke S; Krieglstein GK
Graefes Arch Clin Exp Ophthalmol; 2000 Nov; 238(11):905-9. PubMed ID: 11148814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
